BIOVECTRA Signs mRNA Tech Deal
Charlottetown’s BIOVECTRA has reached a key milestone in its plans to develop one of Canada’s first mRNA vaccine manufacturing facilities, having inked a deal with pharma startup Acuitas to use the Vancouver-based company’s manufacturing technology.
Acuitas specializes in using lipid nanoparticles to deliver vaccines and other medications, with lipids being a class of organic compounds that